Mercury Labs

Market Cap: Micro Cap
Industry: Pharmaceuticals & Drugs
ISIN: INE947G01011
NSEID:
BSEID: 538964

INR

823.80

7.25 (0.89%)

BSENSE

Apr 11, 11:42 AM

BSE+NSE Vol: 1

Click here to access the older version

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Divi's Lab.

Cipla

Sun Pharma.Inds.

Torrent Pharma

Mercury Labs

Makers Labs.

Mankind Pharma

Biofil Chemicals

Lasa Supergeneri

Ind-Swift

Welcure Drugs

Why is Mercury Laboratories Ltd ?

Poor long term growth as Operating profit has grown by an annual rate -3.04% of over the last 5 years

Flat results in Dec 24

PAT(HY) At Rs 1.69 cr has Grown at -38.55%
CASH AND CASH EQUIVALENTS(HY) Lowest at Rs 2.67 cr

Stock is technically in a Bearish range

The technical trend has deteriorated from Mildly Bearish on 24-Mar-25 and has generated -1.81% returns since then
Multiple factors for the stock are Bearish like MACD, Bollinger Band and KST

Underperformed the market in the last 1 year

Even though the market (BSE 500) generated negative returns of -0.91% in the last 1 year, its fall in the stock was much higher with a return of -11.61%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Drugs)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Mercury Labs for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Mercury Labs

-11.61%

-0.22

52.13%

SENSEX

0.45%

0.03

14.48%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

4.52%

EBIT Growth (5y)

-3.04%

EBIT to Interest (avg)

5.26

Debt to EBITDA (avg)

0.89

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

1.42

Tax Ratio

27.84%

Dividend Payout Ratio

7.43%

Pledged Shares

Institutional Holding

ROCE (avg)

12.74%

ROE (avg)

10.73%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.90

EV to EBIT

21.35

EV to EBITDA

13.23

EV to Capital Employed

1.86

EV to Sales

1.39

PEG Ratio

Dividend Yield

0.43%

ROCE (Latest)

9.23%

ROE (Latest)

7.62%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company

NET SALES(Q)

Highest at Rs 19.57 cr

-6What is not working for the Company

PAT(HY)

At Rs 1.69 cr has Grown at -38.55%

CASH AND CASH EQUIVALENTS(HY)

Lowest at Rs 2.67 cr

Loading Valuation Snapshot...

Here's what is working for Mercury Labs

Net Sales - Quarterly

Highest at Rs 19.57 cr

in the last five quarters

MOJO Watch

Near term sales trend is positive

Net Sales (Rs Cr)

Here's what is not working for Mercury Labs

Profit After Tax (PAT) - Half Yearly

At Rs 1.69 cr has Grown at -38.55%

Year on Year (YoY)

MOJO Watch

Near term PAT trend is negative

PAT (Rs Cr)

Cash and Cash Equivalents - Half Yearly

Lowest at Rs 2.67 cr

in the last six half yearly periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents